Stay updated with breaking news from Forefront Analytics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Forefront Analytics LLC increased its stake in iShares Global REIT ETF (NYSEARCA:REET – Free Report) by 18.6% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 14,744 shares of the company’s stock after purchasing an additional 2,313 shares during the quarter. Forefront Analytics LLC’s […]
Jaffetilchin Investment Partners LLC cut its stake in shares of iShares Floating Rate Bond ETF (BATS:FLOT – Free Report) by 62.2% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 105,831 shares of the company’s stock after selling 174,469 shares during the period. Jaffetilchin Investment Partners […]
ALX Oncology Holdings Inc. (NASDAQ:ALXO – Free Report) – Investment analysts at Lifesci Capital issued their Q3 2023 earnings estimates for shares of ALX Oncology in a report released on Friday, August 11th. Lifesci Capital analyst S. Slutsky anticipates that the company will earn ($0.79) per share for the quarter. Lifesci Capital has a “Outperform” […]
Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) was the recipient of a significant decline in short interest in the month of July. As of July 31st, there was short interest totalling 6,200,000 shares, a decline of 19.5% from the July 15th total of 7,700,000 shares. Based on an average daily volume of 1,830,000 […]
Oppenheimer restated their outperform rating on shares of Orchard Therapeutics (NASDAQ:ORTX – Free Report) in a research report released on Wednesday morning, Benzinga reports. They currently have a $34.00 target price on the stock. Separately, Cantor Fitzgerald restated an overweight rating on shares of Orchard Therapeutics in a report on Monday, May 15th. Get Our […]